All
Laser-assisted PDT clears AK lesions
July 1st 2002Atlanta - A pilot study of laser-assisted photodynamic therapy(PDT) indicates that the technique could offer several advantages over otherforms of treatment for actinic keratoses, said Macrene Alexiades-Armenakas,M.D., Ph.D., director of research, Laser and Skin Surgery Center of NewYork.
Port-wine stains respond to dynamic cooling, long pulses
July 1st 2002Atlanta - When a port-wine stain has persisted despite conventional pulsed-dyelaser therapy, it may respond to a modality combining dynamic cooling andlong-pulse durations, according to Catherine M. Gorst, N.P. This systemmay cause at least a 50 percent lightening in resistant lesions, she said.
Excimer laser repigments facial scars
July 1st 2002Atlanta - Two recent studies suggest that the 308nm excimer laser may be the first device effective in the treatment of hypopigmented facial scars, striae, and hypopigmentation caused by resurfacing with the CO2 laser. Both studies were presented at the 22nd annual meeting of the American Society for Laser Medicine and Surgery.
Levels of sedation require derm surgeons' adherence
July 1st 2002New Orleans - Sedating patients is a serious business, and dermatologic surgeons need to be well aware of the progressive levels of sedation and ensure that patients are monitored appropriately to prevent complications, J. Lance Lichtor, M.D., said.
Excimer laser benefits some psoriasis, vitiligo patients
July 1st 2002New Orleans - Research studies using the excimer laser to treat vitiligo and psoriasis have confirmed the procedure to be effective and relatively safe. The key to a successful outcome is the proper selection of patients, study author Suhail Hadi, M.D., said at the annual meeting of American Academy of Dermatology.
Targeted phototherapy system clears plaque psoriasis
July 1st 2002New Orleans - A recently introduced high-dose targeted ultraviolet B light system (BClear, Lumenis Inc.) combines traditional UVB light therapy with fiberoptic delivered light technology for the treatment of localized plaque psoriasis and vitiligo.
Terbinafine surpasses comparators for clearing onychomycosis
July 1st 2002New Orleans - In the treatment of onychomycosis, terbinafine (Lamisil) offers better short-term and long-term efficacy relative to other oral antifungal agents, Bernard J. Cribier, M.D., Ph.D., said at the annual meeting of the American Academy of Dermatology.
Use 12 techniques to deal with difficult patients
June 1st 2002I will never forget one of my female patients who had a neurogenic bladder.She was using disposable catheters for self-intermittent catheterizationand called our office to obtain a box of them. My nurse told her that wehad the catheters and that she would bring the box out to the patient'scar if she would call from her cell phone when she was in front of the building.The nurse also mentioned the cost of the catheters, according to our officepolicy to charge for durable medical goods.
Arachnophlebectomy needle proves effective for leg telangiectasias
June 1st 2002Las Vegas - Destruction of veins by a sharp-tipped needle maybe a more effective approach to leg telangiectasias than sclerotherapy,according to Linda Woodson, M.D. She views this new modality as an appropriatestrategy for sites that have been resistant to sclerotherapy, rather thanas a first-line therapy.
Assay reassures 'not all allergens created equal'
June 1st 2002New Orleans - Studies have shown that the local lymph node assay(LLNA) in mice can be used to provide quantitative estimates of the relativeskin sensitizing potency of various product ingredients, and these valuescorrelate closely with what is known of the ability of chemicals to causeskin sensitization in humans, G. Frank Gerberick, Ph.D., said at the annualAmerican Academy of Dermatology meeting.
Corticosteroid foams benefit acne keloidalis nuchae
June 1st 2002New Orleans - Clobetasol propionate and betamethasone valerate in a foam vehicle are effective for the treatment of acne keloidalis nuchae and have the advantage of better cosmetic acceptability compared with other formulations of topical steroids, Valerie D. Callender, M.D., said at the annual meeting of the American Academy of Dermatology.